Dendrite cells in peripheral blood patients with systemic lupus erythematosus;Komórki dendrytyczne we krwi obwodowej chorych na układowy toczén rumieniowaty

Acta Haematologica Polonica

Volumn 35, Issue 3, 2004, Pages 351-362

  Robak, Ewa ^a   Trzcńska, Ewa ^a   Smolewski, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Dendritic cells; Lymphocytes; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; CD123 ANTIGEN; CD32 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; BONE MARROW; BONE MARROW CELL; CELL COUNT; CORRELATION ANALYSIS; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEUKOCYTE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 10644221940     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Swaak AJ, Nossent JC, Smeek RJ. Systemic lupus erythematosus. Int J Clin Lab Res. 1992; 22: 190-195.
2. Hang L, Theofilopoulos AN, Balderas RS i wsp. The effect of thymectomy on lupus-prone mice. J Immunol. 1984; 132: 1809-1813.
3. Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med. 1985; 161: 378-391.
4. Cravens P, Lipsky P. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol. 2002; 80: 497-505.
5. Sozzani S, Luini W, Borsatti A. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol. 1997; 159: 1993-2000.
6. Dieu MC, Vanbervliet B, Vicari A. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998; 188: 373-386.
7. Sallusto F, Schaerli P, Loetscher P. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998; 28: 2760-2769.
8. Kadowaki N, Antonenko S, Lau JY i wsp.: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med. 1999; 192: 219-221.
9. Banchefeau J, Briere F, Caux C i wsp.: Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18: 767-811.
10. Palucka AK, Banchereau J, Blanco P i wsp.: The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol Cell Biol. 2002; 80: 484-488.
11. Caux C, Massacrier, Vauberviliet B i wsp.: CD34+ hematopoetic progenitors form human cord blood differentiation along two independent dendritic cell patways in response to granulacyte-macrophage colony-stimulating factor alfa: II Functional analysis. Blood. 1997; 90: 1458-1470.
12. Dzionek A, Fuchs A, Schmidt P i wsp.: BDCA-2, BDCA-3 and BDCA-4 three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000; 165: 6037-6046.
13. Craveus PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory disease. Immunol Cell Biol. 2000; 80: 497-505.
14. Blomberg S, Eloranta ML, Magusson M i wsp. Expression of the markers BDCA-2 and BDCA-4 and production of interferon alfa by plasmocytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 2003; 48: 2524-2532.
15. Farkas L, Beiske K, Lund-Johansen N i wsp.: Plasmocytoid dendritic cell natural interferon-α/β-producing cells accumulatein cutaneus lupus erythematosus lesions. Am J Pathol. 2001; 109: 237-243.
16. Siegal FP, Kadowski N, Shodel M i wsp.: The nature of principal type 1 interferon producing cells in human blood. Science. 1999; 284: 1835-1837.
17. Pascual V, Bancheveau J, Palucka AK. The central role of dendritic cells and interferon- alfa in SLE. Curr Opin Rheumatol. 2003; 15: 548-556.
18. Cella M, Jarrossay D, Facchetti F i wsp. Plasmocytoid monocytes migrate to inflamed lymph node and produce large amounts of type I interferon. Nat Med. 1999; 4: 919-923.
19. Shoedel M, Shah K, Siegal FP. Ciculating human plasmocytoid dendritic cells are highly to sensitive to corticosteroid administration. Lupus. 2003; 12: 222-230.
20. Siegal FP, Kadowski N, Shodel M i wsp. The nature of principal type 1 interferon producing cells in human blood. Science. 1999; 284: 1835-1837.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725.
22. Liang MM, Socher SA, Larson MG i wsp.: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
23. Scheinecker C, Zwolfer B, Koller M i wsp.: Alterations of dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 2001; 44: 856-865.
24. Gill MA, Blanco P, Arce E i wsp. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol. 2002; 63: 1172-1180.
25. Ernlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994; 152: 3685-3692.
26. Lorenz HM, Grunke M, Hieronymus M i wsp.: In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 1997; 40: 306-317.
27. Petterson S, Helbert M, English NR, Pinching AJ, Knight SC. The effect of AZT on dendritic cell number and provirus load in the peripheral blood of AIDS patients: a preliminary study. Res Virol. 1996; 147: 109-114.
28. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res. 1997; 3: 483-490.
29. Pascual V, Banchereau J, Palucka AK. The central role of dendritic cells and interferon-alpha in SLE. Curr. Opin. Rheumatol. 2003; 15: 548-556.
30. Robak E, Sysa-Jȩdrzejowska A, Dziankowska B i wsp. Association of interferon-γ tumor necrosis factor-α and interleukin-6 serum levels with systemic lupus erythematosus activity. Arch. Immunol. Ther. Exp. 1998; 46: 375-380.
31. Lacki JK, Leszczyński P, Kelemcn J i wsp.: Cytokine concentration in serum of lupus erythematosus patients: the effect on acute response. J Med. 1997; 28: 99-107.
32. Ronnblom L, Alm GV. A pivotal role for the natural interferon alpha producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med. 2001; 194: 59-63.
33. Ehrenstein MR, McSweeney E, Swana M i wsp.: Appearance of anti-DNA antibodies in patients treated with interferon-alpha. Arthritis Rheum. 1993; 36: 279-280.
34. Flores A, Olive A, Feliu E. Systemic lupus erythematosus following interferon therapy. Br J Rheum. 1994; 33: 787.
35. Tolaymat A, Leventhal B, Sakarcan A i wsp.: Systemic lupus erythematosus in child receiving long term interferon therapy. J. Pediatr. 1992; 120: 429-432.
36. Blomberg S, Eloranta ML, Cederblad B i wsp.: Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 2001; 10: 484-490.
37. Robak T. Biologia i farmakologia cytokin. Wydawnictwo Naukowe PWN Warszawa-Łódź 1995.
38. Funauchi M, Sugishima M, Minoda M, Horiuchi A. Effect of interferon-gamma on β-lymphocytes of patients with systemic lupus erythematosus. J Rheumatol. 1991; 18: 368-372.
39. Linker-Israeli M. Cytokine abnormalities in human lupus. Clin Immunol Immunopatol. 1992; 63: 10-12.